Form 4: Director Michael Foster Acquires Sabra Health Care REIT Stock

Michael J. Foster, a Director at Sabra Health Care REIT, Inc., acquired 8,310 restricted stock units on June 17, 2026, as part of the company's 2009 Performance Incentive Plan.

Summary

• Director Michael J. Foster acquired 8,310 restricted stock units (RSUs) on June 17, 2026.
• These RSUs were granted under Sabra Health Care REIT, Inc.'s 2009 Performance Incentive Plan.
• The units vest in equal monthly installments starting July 17, 2026, and concluding by June 17, 2027, or the day before the next annual stockholders' meeting.
• Following this transaction, Foster beneficially owns 82,043 shares of common stock.
• This total includes 8,310 unvested stock units and 55,016 stock units with deferred payment.
• The filing also includes a Power of Attorney document authorizing representatives to execute SEC filings on behalf of the reporting person.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it represents a standard equity grant to a director rather than a market transaction or significant change in beneficial ownership.

Positives

• Director acquisition of company stock can signal confidence in the company's future prospects.
• The grant of restricted stock units aligns management and director incentives with shareholder value.
• The vesting schedule provides a retention incentive for the director.

Negatives

• The filing details a grant of stock units, not an open market purchase, which may not reflect immediate personal investment conviction.
• A significant portion of the reported beneficial ownership consists of unvested or deferred stock units.

Risks

• The vesting schedule for the RSUs is tied to specific dates, and any early termination of employment could impact the vesting of these units.
• The value of the acquired stock units is subject to market fluctuations and the company's future performance.

Future Outlook

The restricted stock units granted to Michael J. Foster will vest in monthly installments, indicating a phased recognition of ownership and potential future value realization tied to continued service and company performance.

Industry Context

StockSavvy.ai notes that insider grants of equity, such as restricted stock units, are common in the REIT sector as a method to attract, retain, and incentivize key leadership. The structure of these grants, including vesting schedules, is a standard practice for aligning executive interests with long-term shareholder value.

Corporate Governance

Stakeholder Impact

• Shareholders: The grant of RSUs aligns director incentives with long-term company performance, potentially benefiting shareholders if the stock price appreciates.
• Employees: The existence of the 2009 Performance Incentive Plan suggests a broader compensation framework that may also apply to other employees, impacting overall compensation strategy.
• Management: The grant is a standard component of executive and director compensation, reinforcing their commitment to the company.

Next Steps

• Monthly vesting of 8,310 restricted stock units will commence on July 17, 2026.
• The vesting period will conclude by June 17, 2027, or the day before the next annual stockholders' meeting.

Key Dates

Keywords

SEC Form 4, Sabra Health Care REIT, SBRA, Michael J. Foster, Director, Restricted Stock Units, Stock Grant, Beneficial Ownership, Insider Trading, Executive Compensation